Moleculin Biotech Free Cash Flow (Quarterly) Analysis

Moleculin Biotech Inc (MBRX)

3.09 +0.58 (+23.11%) USD | NASDAQ | Nov 14, 16:00

2.93 -0.16 (-5.18%) After-Hours: 04:47

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
September 30, 2024	-6.113M
June 30, 2024	-5.962M
March 31, 2024	-6.717M
December 31, 2023	-5.488M
September 30, 2023	-7.579M
June 30, 2023	-5.141M
March 31, 2023	-6.017M
December 31, 2022	-7.256M
September 30, 2022	-7.577M
June 30, 2022	-8.062M
March 31, 2022	-4.811M
December 31, 2021	-4.258M
September 30, 2021	-4.288M
June 30, 2021	-6.781M
March 31, 2021	-3.624M
December 31, 2020	-3.14M
September 30, 2020	-5.712M
June 30, 2020	-4.951M

Date	Value
March 31, 2020	-4.344M
December 31, 2019	-4.687M
September 30, 2019	-3.335M
June 30, 2019	-5.366M
March 31, 2019	-3.862M
December 31, 2018	-3.224M
September 30, 2018	-3.114M
June 30, 2018	-3.467M
March 31, 2018	-2.815M
December 31, 2017	-2.406M
September 30, 2017	-1.619M
June 30, 2017	-1.936M
March 31, 2017	-1.391M
December 31, 2016	-1.18M
September 30, 2016	-0.961M
June 30, 2016	-1.355M
March 31, 2016	-0.29M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-8.062M

Minimum

Jun 2022

-3.14M

Maximum

Dec 2020

-5.625M

Average

-5.60M

Median

Free Cash Flow (Quarterly) Benchmarks